0001144204-14-040621.txt : 20140701 0001144204-14-040621.hdr.sgml : 20140701 20140701115722 ACCESSION NUMBER: 0001144204-14-040621 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140701 DATE AS OF CHANGE: 20140701 EFFECTIVENESS DATE: 20140701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRAINSTORM CELL THERAPEUTICS INC. CENTRAL INDEX KEY: 0001137883 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 208133057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-220150 FILM NUMBER: 14951393 BUSINESS ADDRESS: STREET 1: 605 THIRD AVENUE STREET 2: 34TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10158 BUSINESS PHONE: 646-666-3188 MAIL ADDRESS: STREET 1: 605 THIRD AVENUE STREET 2: 34TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10158 FORMER COMPANY: FORMER CONFORMED NAME: BRAINSTORM CELL THERAPEUTICS INC DATE OF NAME CHANGE: 20041122 FORMER COMPANY: FORMER CONFORMED NAME: GOLDEN HAND RESOURCES INC DATE OF NAME CHANGE: 20030827 FORMER COMPANY: FORMER CONFORMED NAME: WIZBANG TECHNOLOGIES INC DATE OF NAME CHANGE: 20010409 D 1 primary_doc.xml X0707 D LIVE 0001137883 BRAINSTORM CELL THERAPEUTICS INC. 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 646-666-3188 DELAWARE Golden Hand Resources Inc. BRAINSTORM CELL THERAPEUTICS INC GOLDEN HAND RESOURCES INC WIZBANG TECHNOLOGIES INC Corporation true Liat Sossover 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Executive Officer Chen Schor 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Robert Shorr 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Irit Arbel 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Alon Pinkas 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Malcolm S. Taub 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Mordechai Friedman 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Chaim Lebovits 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Executive Officer Anthony Fiorino 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Executive Officer Uri Yablonka 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Executive Officer Director Biotechnology Decline to Disclose 06b false 2014-06-19 false true true true false 0 Maxim Group LLC 120708 Maxim Group LLC 120708 405 LEXINGTON AVE. NEW YORK NY NEW YORK 10174 All States false 10500000 10500000 0 false 11 724500 0 In addition to payment of cash consideration, the Issuer will issue to Maxim Group LLC a 3-year warrant to purchase up to 1,260,000 shares of Common Stock, with an exercise price equal to $0.30. 0 true BRAINSTORM CELL THERAPEUTICS INC. /s/ Anthony Fiorino Anthony Fiorino Chief Executive Officer 2014-06-30